HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)

structure given in first source; RN given is for 6alpha isomer
Also Known As:
PMTS; pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate, 6beta-isomer
Networked: 56 relevant articles (0 outcomes, 7 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Fukayama, Masashi: 3 articles (01/2015 - 01/2015)
2. Tajima, Shogo: 3 articles (01/2015 - 01/2015)
3. Steiner, Meir: 3 articles (12/2011 - 01/2005)
4. Bruce, J L: 2 articles (05/2015 - 07/2014)
5. Oosthuizen, G V: 2 articles (05/2015 - 07/2014)
6. Clarke, D L: 2 articles (05/2015 - 07/2014)
7. Laing, G L: 2 articles (05/2015 - 07/2014)
8. Carter, Jodi M: 2 articles (03/2015 - 01/2015)
9. Folpe, Andrew L: 2 articles (03/2015 - 01/2015)
10. Ben Mamoun, Choukri: 2 articles (01/2015 - 07/2011)

Related Diseases

1. Premenstrual Syndrome (Premenstrual Tension)
2. Neoplasms (Cancer)
3. Tachycardia (Tachyarrhythmias)
11/01/1992 - "Pacemaker mediated tachycardias (PMTs) are a well known complication of P synchronous pacing. "
10/09/2013 - "Two hundred fifty consecutive patients (71±14 years, 63% male) implanted for symptomatic second- or third-degree AV block were screened for retrograde VA conduction and related PMTs including endless loop tachycardia (ELT) and repetitive nonreentrant VA synchrony (RNRVAS). "
03/01/1984 - "Programmed single ventricular extrastimulation demonstrated that: (1) merely the presence of VA conduction during EPS, although necessary, was not sufficient to induce PMTs after DDD pacemaker implantation; (2) VPBs introduced late rather than early in the cardiac cycle initiated PMTs in a different way; (3) the initiation of PMTs could be prevented during study by adjusting the programmable parameters (AV delay period, upper rate limit, tachycardia response); (4) one of the two available tachycardia responses of the pulse generator (gradual fall-back response) was able to terminate and initiate PMTs consistently. "
03/01/1984 - "To evaluate factors playing a role in initiation and perpetuation of pacemaker-mediated tachycardias (PMTs), 22 consecutive patients with symptomatic conduction disorders were studied after implantation of an AV universal (DDD) pulse generator (Cordis 233D). "
03/01/1984 - "PMTs could be initiated in six of eight patients of Group I and in none of 14 patients of Group II. Initiation and perpetuation of PMTs during DDD pacing were dependent upon the capacity of the patient to conduct ventricular premature beats (VPBs) and subsequent paced ventricular beats retrogradely to the atria, and upon three programmable parameters of the pulse generator (AV delay period, upper rate limit, tachycardia response). "
4. Wounds and Injuries (Trauma)
5. Osteomalacia

Related Drugs and Biologics

1. Dichlorodiphenyldichloroethane (DDD)
2. Methyltransferases
3. Oncogenic osteomalacia
4. phosphorylethanolamine (phosphoethanolamine)
5. Myogenin
6. Somatostatin Receptors (Somatostatin Receptor)
7. Messenger RNA (mRNA)
8. Pyridoxine (Pyridoxin)
9. Proteins (Proteins, Gene)
10. Prolactin

Related Therapies and Procedures

1. Therapeutics
2. Palliative Care (Palliative Medicine)
3. Aftercare (After-Treatment)